Time‐resolved X‐ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine

Haleblian, 1969, Pharmaceutical applications of Polymorphism, J Pharm Sci, 58, 911, 10.1002/jps.2600580802 Byrn, 1995, Pharmaceutical Solids — A strategic approach to regulatory considerations, Pharm Res, 12, 945, 10.1023/A:1016241927429 Brodie, 1996, Drug therapy‐Antiepileptic drugs, New Eng J Med, 334, 168, 10.1056/NEJM199601183340308 Kahela, 1983, Pharmacokinetics and dissolution of two crystalline forms of carbamazepine, Int J Pharm, 14, 103, 10.1016/0378-5173(83)90118-7 Terrence, 1983, Effect of Baclofen enantiomorphs on the spinal trigeminal nucleus and steric similarities of carbamazepine, Pharmacology, 27, 85, 10.1159/000137839 Pohlmann, 1975, Polymorphie, Teilchengrosse und Blutspiegelwerte von carbamazepin, Pharmazie, 30, 709 Lowes, 1987, Physicochemical properties and X‐ray structural studies of the trigonal polymorph of carbamazepine, J Pharm Sci, 76, 744, 10.1002/jps.2600760914 Reboul, 1981, 5H‐5‐Dibenzyl(B,F)azepinecarboxamide (carbamazepine), Acta Crystallogr B, B37, 1844, 10.1107/S0567740881007383 Ceolin, 1997, X‐ray characterization of the triclinic polymorph of carbamazepine, J Pharm Sci, 86, 1062, 10.1021/js960338k Krahn, 1987, Relations between several crystal forms and the dihydrate of carbamazepine, Pharm Acta Helv, 62, 247 Kala, 1986, Zur Polymorphie des carbamazepins, Acta Pharm Technol, 32, 72 Umeda, 1984, Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state, Yakugaku Zasshi, 104, 786, 10.1248/yakushi1947.104.7_786 Kaneniwa, 1984, Hygroscopicity of carbamazepine crystalline powders, Yakugashi Zasshi, 104, 184, 10.1248/yakushi1947.104.2_184 Rustichelli, 2000, Solid‐state study of polymorphic drugs: Carbamazepine, J Pharm Biomed Anal, 23, 41, 10.1016/S0731-7085(00)00262-4 Behme, 1991, Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple‐phase changes during differential scanning calorimetry analysis, J Pharm Sci, 80, 986, 10.1002/jps.2600801016 Suryanarayanan, 1989, Determination of the relative amounts of anhydrous carbamazepine and carbamazepine dihydrate in a mixture by X‐ray diffraction, Pharm Res, 6, 1017, 10.1023/A:1015970218980 Suryanarayanan, 1990, Determination of the relative amounts of αα‐carbamazepine and βα‐carbamazepine in a mixture by powder X‐ray diffractometry, Powder Diffraction, 5, 155, 10.1017/S0885715600015608 Han, 1998, Influence of the enviromental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate, Pharm Dev Technol, 3, 587, 10.3109/10837459809028643 Li, 2000, In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine, Pharm Dev Technol, 5, 257, 10.1081/PDT-100100540 Lefebvre, 1986, Polymorphic transitions of carbamazepine during grinding and compression, Drug Dev Ind Pharm, 12, 1913, 10.3109/03639048609042617 Borka, 1992, Semiquantitative IR spectroscopy of the crystal polymorphs of carbamazepine – A special case in the Ph.Eur. and USP, Pharm Acta Helv, 67, 231 Ryan, 1997, A synchrotron X‐ray study of melting and recrystallisation in isotactic polypropylene, Polymer, 38, 759, 10.1016/S0032-3861(96)00583-6 Giron, 1995, Thermal‐analysis and calorimetric methods in the characterization of polymorphs and solvates, Thermochim Acta, 248, 1, 10.1016/0040-6031(94)01953-E